AAAAAA
Results:
1-8
|
Results: 8
Authors:
COVENS A
PINKERTON P
OSBORNE R
DEPETRILLO A
Citation: A. Covens et al., REVIEW OF AUTOLOGOUS AND ALLOGENEIC BLOOD-TRANSFUSION PRACTICES IN PATIENTS UNDERGOING RADICAL HYSTERECTOMY, European journal of gynaecological oncology, 18(6), 1997, pp. 449-452
Authors:
COVENS A
THOMAS G
SHAW P
ACKERMAN I
OSBORNE R
LUKKA H
CAREY M
FRANSSEN E
ROCHE K
Citation: A. Covens et al., LEUPROLIDE IN THE TREATMENT OF ENDOMETRIAL CANCER - REPLY, Gynecologic oncology, 66(3), 1997, pp. 542-542
Authors:
COVENS A
THOMAS G
SHAW P
ACKERMAN I
OSBORNE R
LUKKA H
CAREY M
FRANSSEN E
ROCHE K
Citation: A. Covens et al., A PHASE-II STUDY OF LEUPROLIDE IN ADVANCED RECURRENT ENDOMETRIAL CANCER/, Gynecologic oncology, 64(1), 1997, pp. 126-129
Authors:
PINKERTON PH
COVENS A
Citation: Ph. Pinkerton et A. Covens, AUTOLOGOUS BLOOD-TRANSFUSION IN RADICAL HYSTERECTOMY, TRANSFUSION MEDICINE, 6(3), 1996, pp. 223-225
Authors:
COVENS A
BOUCHER S
ROCHE K
MACDONALD M
PETTITT D
JOLAIN B
SOUETRE E
RIVIERE M
Citation: A. Covens et al., IS PACLITAXEL AND CISPLATIN A COST-EFFECTIVE FIRST-LINE THERAPY FOR ADVANCED OVARIAN-CARCINOMA, Cancer, 77(10), 1996, pp. 2086-2091
Authors:
LOCOCO S
COVENS A
CARNEY M
FRANSSEN E
DOGDE R
ROSEN B
OSBORNE R
KERR I
BUCKMAN R
SOPER J
RODRIGUEZ G
DEPETRILLO A
CLARKEPEARSON D
BERCHUCK A
Citation: S. Lococo et al., DOES AGGRESSIVE THERAPY IMPROVE SURVIVAL IN SUBOPTIMAL STAGE-IIIC-IV OVARIAN-CANCER - A CANADIAN-AMERICAN COMPARATIVE-STUDY, Gynecologic oncology, 59(2), 1995, pp. 194-199
Authors:
ELIT L
COVENS A
OSBORNE R
GERULATH A
MURPHY J
ROSEN B
STURGEON J
Citation: L. Elit et al., HIGH-DOSE METHOTREXATE FOR GESTATIONAL TROPHOBLASTIC DISEASE, Gynecologic oncology, 54(3), 1994, pp. 282-287
Authors:
COVENS A
ROSEN B
GIBBONS A
OSBORNE R
MURPHY J
DEPETRILLO A
LICKRISH G
SHAW P
COLGAN T
Citation: A. Covens et al., DIFFERENCES IN THE MORBIDITY OF RADICAL HYSTERECTOMY BETWEEN GYNECOLOGICAL ONCOLOGISTS, Gynecologic oncology, 51(1), 1993, pp. 39-45
Risultati:
1-8
|